Regenimo Biosciences, Inc.

CIK 2096367 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Regenimo Biosciences, Inc..

Recent SEC filings

FiledFormAccession number
Nov 25, 2025D0002096367-25-000001